FTC Supports FDA's Plan To Curb Sham Petitioning
The Federal Trade Commission said Tuesday that it supports the Food and Drug Administration's plan to prevent drug companies from strategically objecting to generic approvals with the aim of delaying competition,...To view the full article, register now.
Already a subscriber? Click here to view full article